森下仁丹の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/10/17 | 2,110 | 2,110 | 2,103 | 2,107 | +7 | +0.3% | 800 |
| 2024/10/16 | 2,106 | 2,110 | 2,100 | 2,100 | -9 | -0.4% | 2,100 |
| 2024/10/15 | 2,143 | 2,143 | 2,109 | 2,109 | -9 | -0.4% | 2,000 |
| 2024/10/11 | 2,110 | 2,118 | 2,101 | 2,118 | +8 | +0.4% | 700 |
| 2024/10/10 | 2,120 | 2,121 | 2,110 | 2,110 | ±0 | ±0% | 600 |
| 2024/10/09 | 2,142 | 2,142 | 2,101 | 2,110 | -5 | -0.2% | 1,800 |
| 2024/10/08 | 2,112 | 2,120 | 2,100 | 2,115 | -5 | -0.2% | 1,200 |
| 2024/10/07 | 2,121 | 2,130 | 2,103 | 2,120 | +2 | +0.1% | 3,900 |
| 2024/10/04 | 2,126 | 2,126 | 2,118 | 2,118 | +3 | +0.1% | 400 |
| 2024/10/03 | 2,119 | 2,119 | 2,115 | 2,115 | -4 | -0.2% | 400 |
| 2024/10/02 | 2,125 | 2,128 | 2,119 | 2,119 | -10 | -0.5% | 1,400 |
| 2024/10/01 | 2,155 | 2,155 | 2,129 | 2,129 | +5 | +0.2% | 600 |
| 2024/09/30 | 2,140 | 2,141 | 2,124 | 2,124 | -16 | -0.7% | 2,200 |
| 2024/09/27 | 2,145 | 2,145 | 2,121 | 2,140 | -5 | -0.2% | 500 |
| 2024/09/26 | 2,145 | 2,146 | 2,135 | 2,145 | +10 | +0.5% | 2,600 |
| 2024/09/25 | 2,144 | 2,144 | 2,126 | 2,135 | +2 | +0.1% | 2,800 |
| 2024/09/24 | 2,119 | 2,145 | 2,110 | 2,133 | +31 | +1.5% | 2,800 |
| 2024/09/20 | 2,091 | 2,111 | 2,090 | 2,102 | +10 | +0.5% | 2,400 |
| 2024/09/19 | 2,073 | 2,092 | 2,073 | 2,092 | +21 | +1% | 1,500 |
| 2024/09/18 | 2,096 | 2,096 | 2,070 | 2,071 | -1 | ±0% | 700 |
| 2024/09/17 | 2,087 | 2,087 | 2,070 | 2,072 | +3 | +0.1% | 1,000 |
| 2024/09/13 | 2,066 | 2,085 | 2,061 | 2,069 | +3 | +0.1% | 1,300 |
| 2024/09/12 | 2,056 | 2,066 | 2,044 | 2,066 | +11 | +0.5% | 1,800 |
| 2024/09/11 | 2,075 | 2,075 | 2,055 | 2,055 | -2 | -0.1% | 1,000 |
| 2024/09/10 | 2,055 | 2,059 | 2,046 | 2,057 | +13 | +0.6% | 700 |
| 2024/09/09 | 2,050 | 2,058 | 2,041 | 2,044 | -20 | -1% | 3,100 |
| 2024/09/06 | 2,064 | 2,066 | 2,061 | 2,064 | ±0 | ±0% | 1,000 |
| 2024/09/05 | 2,065 | 2,075 | 2,061 | 2,064 | -1 | ±0% | 900 |
| 2024/09/04 | 2,081 | 2,099 | 2,065 | 2,065 | -31 | -1.5% | 2,000 |
| 2024/09/03 | 2,083 | 2,124 | 2,076 | 2,096 | +25 | +1.2% | 2,100 |
| 2024/09/02 | 2,089 | 2,089 | 2,071 | 2,071 | -1 | ±0% | 1,700 |
| 2024/08/30 | 2,060 | 2,076 | 2,051 | 2,072 | +9 | +0.4% | 1,800 |
| 2024/08/29 | 2,050 | 2,063 | 2,050 | 2,063 | +8 | +0.4% | 900 |
| 2024/08/28 | 2,048 | 2,055 | 2,047 | 2,055 | +6 | +0.3% | 1,200 |
| 2024/08/27 | 2,060 | 2,066 | 2,049 | 2,049 | +1 | ±0% | 1,200 |
| 2024/08/26 | 2,053 | 2,053 | 2,043 | 2,048 | -16 | -0.8% | 1,400 |
| 2024/08/23 | 2,040 | 2,072 | 2,039 | 2,064 | +26 | +1.3% | 3,700 |
| 2024/08/22 | 2,040 | 2,045 | 2,038 | 2,038 | -8 | -0.4% | 2,200 |
| 2024/08/21 | 2,039 | 2,046 | 2,033 | 2,046 | +2 | +0.1% | 1,200 |
| 2024/08/20 | 2,044 | 2,049 | 2,034 | 2,044 | +9 | +0.4% | 4,600 |
| 2024/08/19 | 2,033 | 2,044 | 2,032 | 2,035 | +3 | +0.1% | 2,200 |
| 2024/08/16 | 2,031 | 2,036 | 2,031 | 2,032 | +2 | +0.1% | 2,800 |
| 2024/08/15 | 2,030 | 2,035 | 2,019 | 2,030 | ±0 | ±0% | 2,500 |
| 2024/08/14 | 2,016 | 2,033 | 2,012 | 2,030 | +10 | +0.5% | 3,200 |
| 2024/08/13 | 2,036 | 2,036 | 2,013 | 2,020 | +7 | +0.3% | 1,900 |
| 2024/08/09 | 2,040 | 2,040 | 2,010 | 2,013 | -27 | -1.3% | 6,300 |
| 2024/08/08 | 2,055 | 2,060 | 2,035 | 2,040 | -5 | -0.2% | 4,500 |
| 2024/08/07 | 2,044 | 2,058 | 2,031 | 2,045 | +1 | ±0% | 1,700 |
| 2024/08/06 | 2,043 | 2,167 | 2,015 | 2,044 | -49 | -2.3% | 7,700 |
| 2024/08/05 | 2,079 | 2,167 | 2,019 | 2,093 | -31 | -1.5% | 17,000 |
151～
200
件表示中 / 3711件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 仁 丹 | 211,400円 | +0.3% | +9.2% | 3.07% | 12.01倍 | 0.71倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| ＰＲＩＳＭＢｉｏ | 25,100円 | +14.8% | - | 0.00% | - | 3.01倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
| ＮＡＮＯ | 12,900円 | -30.6% | - | 0.00% | - | 3.34倍 |
|
ｍＲＮＡ医薬品に特化した創薬ベンチャー。創薬シーズ発掘から非臨床開発まで手がけて導出 |
| ケイファーマ | 72,600円 | - | - | 0.00% | - | 3.73倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞による再生医療と創薬の２本柱。中枢神経系が得意領域 |
| シンバイオ | 17,100円 | -24.2% | - | 0.00% | - | 2.15倍 |
|
導入で新薬開発・製品化。抗がん剤「トレアキシン」国内販売。抗ウイルス薬ＢＣＶの開発に注力 |
市場注目の銘柄
チャート関連のコラム
